|
| Exchange Disseminated Time | Gufic Biosciences Ltd has informed BSE that the members at the 22nd Annual General Meeting (AGM) of the Company held on September 28, 2006, inter alia, have accorded to the following:
1. Adoption of the Audited Balance Sheet as at March 31, 2006, the Profit and Loss Account for the year ended as on that date and the Reports of the Board of Directors and the Auditors thereon.
2. Declaration of Dividend @ 16% on Equity Shares.
3. Re-appointment of Mr. Vijay Agarwal & Mr. K N Sanghavi as Director of the Company.
4. Appointment of M/s. Mayur Chokshi & Co., Chartered Accountant, as Statutory Auditor of the Company in place of retiring Auditor M/s. SHR & Co., Chartered Accountant. |
|
|